Medtronic (MDT) beat estimates for profits in the last quarter thanks to strong demand for diabetes and heart ...

Truist Financial analyst Richard Newitter maintained a Hold rating on Medtronic (MDT – Research Report) today and set a price target of $93.00.

Shares of Medtronic PLC MDT rallied 2.27% to $89.94 Friday, on what proved to be an all-around poor trading session for the ...

Medtronic beat Wall Street estimates for third-quarter profit on Tuesday, partly helped by demand for its diabetes devices, ...

Medtronic on Tuesday missed Wall Street estimates for third-quarter revenue due to lower purchases of its surgical devices by ...

Shares of Medtronic PLC MDT advanced 1.08% to $87.94 Thursday, on what proved to be an all-around rough trading session for ...

The first-ever pacemaker to include Managed Ventricular Pacing (MVP®), the EnRhythm™ Pacing System promotes intrinsic conduction and is clinically proven to significantly reduce unnecessary ...

(Reuters) - Medtronic beat Wall Street estimates for third-quarter profit on Tuesday, partly helped by demand for its diabetes devices, but shares fell more than 5% in early trading as it saw ...

Medtronic (MDT) stock falls after seeing a revenue decline in its surgical portfolio for the fiscal third quarter. Stay up to date on the latest market action, minute-by-minute, with&nbsp ...

(Reuters) - Medtronic beat Wall Street estimates for quarterly profit on Tuesday, on strong demand for its heart and diabetes devices. Investors have high expectations of medical device makers as they ...

(Reuters) - Medtronic on Tuesday missed Wall Street estimates for third-quarter revenue due to lower purchases of its surgical devices by distributors and said the problems would persist in the ...